Recently, the co-founder of Germany's BioNTech company said in an interview with the media that the cancer vaccine they developed through mRNA technology is expected to be launched before 2030. Once the
remarks were published, they immediately caused heated discussion. The well-known academic journal "The Lancet" sub-job "THE LANCET Oncology" specially published an article to discuss this, believing that mRNA cancer vaccine and are a new opportunity for the treatment of early cancer patients or postoperative patients .
They searched for the development of mRNA technology in the past 20 years and found that as early as 1996, the academic community had discovered some of its potential in cancer treatment.
Now, after decades of technological development in the academic community, the structure and stability of mRNA and the drug delivery method have been optimized.
From a variety of clinical experiments on this technology at home and abroad, including lung cancer, colorectal cancer, pancreatic cancer, , and head and neck tumors, solid tumors: mRNA combined with other immune strategies can prevent or delay the recurrence of the disease and potentially prolong the patient's survival, showing encouraging results.
can also be used in the meantime, given that in most clinical explorations, mRNA cancer vaccines are therapeutic rather than preventive vaccines.
Industry insiders said that is not very useful for healthy groups who want to "prevent problems from the problem" . It may be more reliable for them to improve their physical protection through relatively mature science and technology or a healthy daily lifestyle.
For example, Harvard University professor of genetics Sinclair once found that after supplementing a core component called "Ruoying" technology, many physical indicators of elderly volunteers can be reversed to the level of young and middle-aged people in his related experiments in the "field of age reversal".
2021, this result was certified by the domestic Guangzhou Sports College . They conducted a randomized double-blind comfort control experiment on 48 ordinary middle-aged people aged 27 to 50, and the entire cycle lasted for 6 weeks.
Experiment requires participants to perform 40 to 60 minutes of aerobic exercise for every day, such as jogging or cycling, etc.
result test showed that after ingesting such substances, the muscle endurance and overall function of the middle-aged experimental group were improved, while the control group had little change compared to usual.
Similar research results were confirmed in experiments in research institutions such as Harvard University, University of New South Wales , Chinese Academy of Sciences . volunteers who are nearly 70 years old have positively improved their physiological aging measurement indicators, including cells and muscle strength, after taking "reverse" preparations.
At present, many countries including China, the United States, and Japan have conducted relevant research on it . In March 2020, Japan also included it in the "Legal Food Raw Materials" and hopes to use relevant technologies to develop, and hopes to use such technologies to alleviate the increasingly serious problems of local aging in the long run.
More than 0 mature high-net-worth groups from JD also believe that they have tried related technologies and have also shown some positive reactions in their bodies. "I don't know if it's a psychological effect, but my physical condition and sleep make me feel better."
0 Let me say that, as a super-precision body, the human body has super strong self-protection ability. The effect of technology itself is just to assist its condition in a better and more normal manner. This is similar to our usual car maintenance and refueling. instead of "feeling the body warning yourself that there is danger."
At present, according to data from various countries, although many mRNA cancer vaccine-related clinical trials are still in the early stages of research, research in related fields is progressing very quickly.
For example, in November last year, BioNTech cancer vaccine BNT111 obtained the FDA fast track qualification, and the next step of research is now underway. Overall, the performance of mRNA technology in the field of cancer treatment is worth looking forward to .
